United States Blood Transfusion Diagnostics Market - Forecasts Begin in 2015 and End in 2018 with a Base Year of 2014

News provided by

Research and Markets

09 Apr, 2015, 14:26 GMT

DUBLIN, Apr. 09, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/8ttnzm/the_us_blood) has announced the addition of the "The US Blood Transfusion Diagnostics Market " report to their offering

Continue Reading
This image opens in the lightbox
600769
This image opens in the lightbox
Research and Markets

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed.

The majority of the quantitative and qualitative information contained in this research service was acquired through primary research conducted with blood banking product providers. Most consultations were conducted with vice presidents (VPs) of business units, VPs of marketing, product managers, marketing managers, marketing directors, and business development directors from various competitors in the liquid handling market.

Key Topics Covered:

1. Executive Summary

  • Key Findings
  • Scope and Segmentation
  • Market Segmentation
  • Key Questions This Study Will Answer
  • Market Engineering Measurements
  • CEO's Perspective
  • Key Companies to Watch

2. Market Overview

  • Market Background
  • Market Background-Types of Blood Bank Analyzers
  • Comparison of Immunohematology Methods
  • Voice of Customer-Factors Governing Equipment Purchase for a Transfusion Laboratory
  • Voice of Customer
  • Market Segmentation
  • Procurement Process
  • Defining Future Healthcare Trends

3. Competitive Playbook

  • New Market Opportunities

4. Drivers, Restraints, and Trends-Total Blood Transfusion Diagnostics Market

  • Market Drivers
  • Market Restraints
  • Market Impact of Top 6 Trends

5. Forecasts and Trends-Total Blood Transfusion Diagnostics Market

  • Market Engineering Measurements
  • Factors Impacting Market Forecasts
  • Revenue Forecast
  • Revenue Forecast Discussion

6. Blood Grouping Segment Analysis

  • Revenue Forecast
  • Revenue Forecast Discussion
  • Test Volume for Abo, Rh, RBC Antigen Typing, Antibody Identification, and Screening
  • Medicare Expenditure for Abo, Rh, and RBC Antigen Typing
  • Test Volume and Pricing Analysis for Blood Grouping Tests
  • Medicare Expenditure for Antibody Screening, Identification, and Cross Matching

7. Disease Screening Segment Analysis

  • Revenue Forecast
  • Revenue Forecast for Serological and Molecular
  • Revenue Forecast Discussion
  • Revenue Forecast Discussion (continued)
  • Test Volume and Pricing Analysis for Disease Screening and NAT Tests
  • Test Volume Serological Donor Screening Tests
  • Cost Comparison per Test for Serological and NAT
  • Most Frequently Ordered Blood Tests by Rank

8. Accredited Transfusion Centers

  • Accredited Immunohematology Reference Laboratories
  • Blood Transfusion Centers

9. Overview of Blood Bank Supply Chain

  • Overview of Supply Chain in Blood Banks
  • Problem Areas and Solution

10. Competitive Environment

  • Market Share
  • Market Share Analysis
  • Product Analysis Blood Grouping
  • Product Analysis Disease Screening (Serological and Molecular)
  • Product Analysis Disease Screening (Molecular Assays)
  • Merger, Acquisition, and Partnership Assessment

11. Company Profiles

  • Immucor
  • Ortho Clinical Diagnostics
  • Beckman Coulter (Danaher)
  • BioRad

12. Key Companies to Watch

  • Quotient Limited (previously known as Alba Bioscience)
  • Immucor
  • Diagast
  • 3Ti (Transfusion & Transplantation Technologies)

13. The Last Word

14. Appendix

For more information visit http://www.researchandmarkets.com/research/8ttnzm/the_us_blood

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net